Cardiff Oncology, Inc. - Special Call Transcript
Good day, and welcome to the Cardiff Oncology KOL call on KRAS in clinical practice for colorectal cancer. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Cardiff Oncology website following the conclusion of the event.
I would now like to turn the call over to your host, Dr. Mark Erlander, Chief Executive Officer at Cardiff Oncology.
Please go ahead, sir.
Thank you, operator, and good morning to all of you that have joined us today for today's key opinion leader event. Before I begin, I'd like to thank LifeSci Advisors for putting this event together as well as our key opinion leaders, Dr. Afsaneh Barzi and Dr. Heinz-Josef Lenz, for their time.
Today's event will focus on KRAS in colorectal cancer, beginning with a discussion by Dr. Barzi on the history of KRAS in clinical practice, the challenges of drug development and effectively targeting KRAS mutations and the current
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
